Invicta Diagnostic Limited IPO
Invicta Diagnostic Limited IPO
Invicta Diagnostic Limited IPO
₹ 272000 / 3200 Shares Shares
Minimum Investment
Invicta Diagnostic Limited IPO
Issues Price
₹80-85 per equity share
Invicta Diagnostic Limited IPO
Open Date
01 Dec 2025
Close Date
03 Dec 2025
Lot Size
1600
Min. Investment
₹ 272000
Issue Price
₹80-85
Listing Date
08 Dec 2025
Issues Size
33,08,800 shares(aggregating up to ₹28.12 crore)
Face Value
₹10 Per Equity Share
Total Shares Offered
3200 Shares
Offered To Public
3200 Shares
Invicta Diagnostic Limited IPO
Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. It provides pathology and radiology testing comprising imaging, radiology, pathology, and teleradiology services under the brand 'PC Diagnostics” through 7 diagnostic centres and a central laboratory across Mumbai in Maharashtra. Invicta Diagnostics Limited, trading as PC Diagnostics, is a Mumbai-based diagnostic services company specializing in integrated pathology and radiology solutions. The company follows a hub‑and‑spoke model across the Mumbai Metropolitan Region, featuring: A flagship hub offering full-spectrum pathology and advanced radiology (CT, MRI) at Thane West Three other centres - Bhayandar, Byculla, Marol - offering specialized diagnostic services Basic imaging, including X-ray and ultrasound, and sample collection were the focus of spokes at Lower Parel, Sewri, Mazgaon, and Kalwa. It offers approximately 60 routine and 487 specialized pathology tests and around 96 basic and 130 advanced radiology investigations. Invicta Diagnostics provides a comprehensive suite of diagnostic services that includes: Routine Tests: Includes CBC, lipid profiles, liver function tests (LFT), kidney function tests (KFT), and thyroid panels Specialized Tests: Molecular diagnostics, immunoassays, infectious disease markers including dengue, COVID-19, cancer markers, and genetic panels. Sample Collection Network: Invicta uses phlebotomists and collection partners to reach patients at home or through its spoke centres. The company has a network of 5 laboratory doctors, 20 radiologists, and 127 well-trained technical staff as of May 31st, 2025. The company has 105 permanent employees as of May 31, 2025.
Founded In
2021
Managing Director
Dr. Ketan Jayantilal Jain
Parent Organization
Invicta Diagnostic Limited IPO
Application for Invicta Diagnostic Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Individual (min) | ₹80-85 | ₹2,72,000 |
| Individual(max) | ₹80-85 | ₹2,72,000 |
| SHNI(min) | ₹80-85 | ₹4,08,000 |
| SHNI(max) | ₹80-85 | ₹9,52,000 |
| BHNI(min) | ₹80-85 | ₹10,88,000 |
Apply for all eligible candidates, Invicta Diagnostic Limited IPO.
Open On12 Dec 2025
Close On16 Dec 2025
Price Range₹2061-2165
Testimonial
Genuine Review Form Statisifed Customers
I appreciated how KSquare simplified the NPS jargon. Everything was laid out clearly with ongoing support.
KSquare offered expert financial advice tailored to NRI needs. Their responsive team and secure platform earned my trust right away.
I needed quick liquidity, and KSquare's loan service was perfect. No need to sell my investments—just smart access.
KSquare stands out with their personalized approach to NRI investing. Their team’s insights and professionalism are unmatched.
KSquare helped me understand what to expect from each NFO. Their breakdown of fund strategy and goals made my investment decision very easy.
KSquare’s team explained everything clearly. I never thought borrowing against my mutual funds would be this easy.
Owning a home seemed difficult, but KSquare’s SIP planning made it achievable. Their regular guidance, timely suggestions, and disciplined investment approach gave me complete financial confidence throughout the journey.
I’ve tested many platforms, but KSquare stands out for their transparency and consistent performance. SIPs with them feel like a smart, hassle-free decision.
KSquare’s loan facility saved me during a financial crunch. I didn’t need to touch my investments—very helpful!
KSquare provided all the guidance I needed to start SIPs. Their plans fit my freelance income, and I’m seeing real results already!
FAQ's
Frequenlty Asked Question
Can I pause or stop my SIP anytime with KSquare?
Yes, KSquare allows you to pause, stop, or modify your SIP plan anytime through your account dashboard.
Do SIPs guarantee returns?
No, SIPs don’t guarantee returns but reduce risk over time and provide the potential for solid, market-linked growth.
What are the charges or fees associated with NFOs?
Like regular funds, NFOs may involve expense ratios and entry/exit loads. KSquare discloses all costs transparently.
How secure is KSquare’s platform for NRI users?
KSquare uses encrypted systems, regulatory safeguards, and secure servers to protect user data and transactions.
How are NPS returns calculated?
NPS returns depend on the performance of the equity, corporate debt, and government bond funds you select within your portfolio.
Is there any penalty for missing a SIP installment?
No penalties are charged by mutual funds for missing SIPs, but your bank may charge ECS failure fees if funds are insufficient.
What types of accounts are required for NRI investments?
NRIs need either an NRE or NRO account to start investing through KSquare, depending on fund repatriation needs.
Can I withdraw my mutual fund investment anytime?
Most mutual funds offer liquidity, allowing you to redeem units anytime, except for closed-ended and ELSS funds with lock-ins.
Ksquare Timeline Pvt. Ltd. is an AMFI Registered Mutual Fund Distributor having ARN No. 146262. Mutual Fund investments are subject to market risks. Please read all scheme related documents carefully before investing. This website is intended only for informational and self-help purposes and should not be considered as investment advice or return guarantee. Past performance is not indicative of future results. Terms & Conditions apply.